Purification, crystallization and X-ray crystallographic analysis of Csm5 in Type III-A Crispr-Cas system

Cited 0 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorYan An-
dc.contributor.authorKwang Hyun Park-
dc.contributor.authorMinho Lee-
dc.contributor.authorWoo-Chan Ahn-
dc.contributor.authorIn-Young Baek-
dc.contributor.authorT J Kim-
dc.contributor.authorEui-Jeon Woo-
dc.date.accessioned2019-01-23T16:30:28Z-
dc.date.available2019-01-23T16:30:28Z-
dc.date.issued2017-
dc.identifier.issn2288-6982-
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/18162-
dc.description.abstractThe CRISPR-Cas system is a microbial adaptive and heritable immune system, of which mechanism relies on the effector ribonucleoprotein (RNP) complex to degrade foreign genetic elements. The effector surveillance complex of the Type III-A CRISPR-Cas system has five Csm components, Csm1~Csm5. The Csm5 protein is placed in the crRNA 3' ends in the effector RNP complex, leading to speculations that crRNA maturation may be catalyzed by the Csm5 subunit. However, the crystal structure and the detailed function of Csm5 still remain elusive. In this study, the Csm5 from Thermococcus onnurineus NA1 was purified and crystallized by the sitting drop method in the condition of 20% w/v PEG 8000 and 100 mM CHES/sodium hydroxide pH 9.5 at 291K. The diffraction data were collected to a resolution of 3.5 A. The crystal belonged to space group P4 3 2 1 2, with unit cell parameters a=81.0 A, b=81.0 A, c=169.1 A. One protomer was presented in the asymmetric unit with a corresponding V M of 2.10 A 3 Da -1 and solvent content of 50%.-
dc.publisherKorea Soc-Assoc-Inst-
dc.titlePurification, crystallization and X-ray crystallographic analysis of Csm5 in Type III-A Crispr-Cas system-
dc.title.alternativePurification, crystallization and X-ray crystallographic analysis of Csm5 in Type III-A Crispr-Cas system-
dc.typeArticle-
dc.citation.titleBiodesign-
dc.citation.number2-
dc.citation.endPage65-
dc.citation.startPage62-
dc.citation.volume5-
dc.contributor.affiliatedAuthorYan An-
dc.contributor.affiliatedAuthorKwang Hyun Park-
dc.contributor.affiliatedAuthorMinho Lee-
dc.contributor.affiliatedAuthorWoo-Chan Ahn-
dc.contributor.affiliatedAuthorIn-Young Baek-
dc.contributor.affiliatedAuthorEui-Jeon Woo-
dc.contributor.alternativeName안연-
dc.contributor.alternativeName박광현-
dc.contributor.alternativeName이민호-
dc.contributor.alternativeName안우찬-
dc.contributor.alternativeName백인영-
dc.contributor.alternativeName김태집-
dc.contributor.alternativeName우의전-
dc.identifier.bibliographicCitationBiodesign, vol. 5, no. 2, pp. 62-65-
dc.description.journalClassN-
Appears in Collections:
Critical Diseases Diagnostics Convergence Research Center > 1. Journal Articles
Synthetic Biology and Bioengineering Research Institute > Genome Editing Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.